We evaluate the performance of the deep-learning tool ModelAngelo in determining de novo antibody sequences directly ... Of the 23 maps, 8 have alignment scores above 50 for both heavy and light chain ...

Claire’s Stores, a global fashion retailer with 3,400+ locations, needed a faster, more efficient fulfillment system to keep up with rising sales and seasonal peaks. Traditional methods had workers ...

Alongside the rebrand, Sequence expands its technical leadership with the strategic acquisition of Light, a pioneer of chain abstraction technologies. The acquisition represents a powerful step ...

The paper addresses the problem of optimising the mapping of serum antibody ... the deposited map, model, and the de novo model generated by ModelAngelo, along with a detailed view of CDRH3. B) ...

Serum free light chain (sFLC) tests have advanced the prediction, diagnosis, and monitoring of plasma cell disorders. This webinar features two leading experts who will compare the performance of sFLC ...

With critical minerals finding applications from clean energy technologies to electronics and defence manufacturing, it has become extremely important for economic development and national security ...

"I hit myself with this big a-- chain," he said with a laugh, referring to the oversize Bud Light chain hanging around his neck. One Philly fan seemed to track down the moment the injury occurred ...

Launched in 2023 and accessible through Alloy's Antibody Discovery Services unit, the ATX-CLC platform enables the expression of common light chain antibodies with full heavy chain diversity, thereby ...

Importantly, it unlocks large-scale analysis of immune repertoires, revealing surprising structural and functional convergence across individuals despite sequence ... heavy or light chain of a ...

player mode is getting a pretty significant refresh with the release of Into the Light, the game's free upcoming content drop, in the form of three new multiplayer maps. The new maps take place in ...

Daratumumab plus bortezomib, cyclophosphamide and dexamethasone is recommended as an option for treating newly diagnosed systemic amyloid light-chain (AL) amyloidosis in adults. It is recommended only ...